AGT and triple-A syndrome: In summary, in the present study, we were able to provide the first evidence that combination therapy with atorvastatin and amlodipine, but not each monotherapy, prevents AngII-induced AAA formation in mice through inhibition of Rho-kinase/CyPA pathway with resultant inhibition of apoptosis, inflammation and MMP activation (Figure 9).